Spero Therapeutics
SPRO
SPRO
59 hedge funds and large institutions have $110M invested in Spero Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $122M → $110M (-$12.4M)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
59
Holding in Top 10
4
Calls
–
Puts
$1K
Top Buyers
| 1 | +$631K | |
| 2 | +$536K | |
| 3 | +$402K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$294K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$279K |
Top Sellers
| 1 | -$3.89M | |
| 2 | -$962K | |
| 3 | -$619K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$325K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$204K |